Application of ionic liquid to polymorphic transformation of anti-viral/HIV drug adefovir dipivoxil.

about

Application of ionic liquid to polymorphic transformation of anti-viral/HIV drug adefovir dipivoxil.

Item

http://www.wikidata.org/entity/Q40892139

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Application of ionic liquid to ...... l/HIV drug adefovir dipivoxil.

@en

type

Item

label

Application of ionic liquid to ...... l/HIV drug adefovir dipivoxil.

@en

prefLabel

Application of ionic liquid to ...... l/HIV drug adefovir dipivoxil.

@en

P1476

Application of ionic liquid to ...... l/HIV drug adefovir dipivoxil.

@en

P2093

Alice Nguvoko Kiyonga

http://www.w3.org/2001/XMLSchema#string

Dong Sun Min

http://www.w3.org/2001/XMLSchema#string

Feng Jin

http://www.w3.org/2001/XMLSchema#string

Hak Sung Kim

http://www.w3.org/2001/XMLSchema#string

Hyuk Min Kim

http://www.w3.org/2001/XMLSchema#string

Hyung Chul Ryu

http://www.w3.org/2001/XMLSchema#string

Jae Sun Kim

http://www.w3.org/2001/XMLSchema#string

Ji-Hun An

http://www.w3.org/2001/XMLSchema#string

Ki Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Kiwon Jung

http://www.w3.org/2001/XMLSchema#string

P2860

Chemistry. Ionic liquids--solvents of the future?

Crystal forms of SK-3530.

Solid state of a new PDE-5 inhibitor DA-8159: characterization, dissolution, transformation.

Polymorph screening: influence of solvents on the rate of solvent-mediated polymorphic transformation.

Crystal forms of atorvastatin.

Polymorphism and pseudopolymorphism of acyclovir.

Approaches to crystallization from ionic liquids: complex solvents-complex results, or, a strategy for controlled formation of new supramolecular architectures?

Polymorphic and kinetic investigation of adefovir dipivoxil during phase transformation.

Crystalline vs. Ionic Liquid Salt Forms of Active Pharmaceutical Ingredients: A Position Paper

Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development

P2888

s12272-016-0721-0

P304

646-659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-016-0721-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045266591

http://www.w3.org/2001/XMLSchema#string

P698

26908332

http://www.w3.org/2001/XMLSchema#string

P921

adefovir dipivoxil